论文部分内容阅读
目的观察马来酸桂哌齐特治疗椎基底动脉供血不足的疗效。方法将60例马来酸桂哌齐特治疗椎基底动脉供血不足患者随机分成两组,30例马来酸桂哌齐特组(观察组)和30例血塞通组(对照组),疗程7d。结果马来酸桂哌齐特组总有效率96.6%;血塞通组为76.6%;两组比较差异有统计学意义(P<0.05)。结论马来酸桂哌齐特治疗椎基底动脉供血不足疗效显著,无不良反应,是一种安全有效的药物。
Objective To observe the efficacy of Cinepazide maleate in the treatment of vertebrobasilar insufficiency. Methods Sixty cases of cinepazide maleate for treatment of vertebrobasilar insufficiency were randomly divided into two groups, 30 cases of cinepazide maleate (observation group) and 30 cases of Xuesaitong (control group). The course of treatment 7d. Results The total effective rate was 96.6% in the cinepazide maleate group and 76.6% in the Xuesaitong group. There was significant difference between the two groups (P <0.05). Conclusion Cinepazide maleate treatment of vertebrobasilar insufficiency with significant effect, no adverse reactions, is a safe and effective drug.